The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
Open accessAbstract
Stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), are rapidly becoming accepted practice for the radiotherapy of certain tumors. Typically SRS and SBRT involve the delivery of one or a few large dose fractions of 8 to 30 Gy per fraction: a major paradigm shift from radiotherapy practice over the past 90 years when, with relatively large amounts of normal tissues receiving high doses, the goal was to maximize tumor response for an acceptable level of normal tissue injury. The development of SRS and SBRT have come about because of technological advances in image guidance and treatment delivery techniques that enable the delivery of large doses to tumors with reduced margins and high gradients outside of the target, thereby minimizing doses to surrounding normal tissues. Because the results obtained with SRS and SBRT have been impressive they have raised the question of whether classic radiobiological modeling, and the linear-quadratic (LQ) model, are appropriate for large doses per fraction. In addition to objections to the LQ model, the possibility of additional biological effects resulting from endothelial cell damage and/or enhanced tumor immunity, have been raised to account for the success of SRS and SBRT. In this review, we conclude that the available preclinical and clinical data do not support a need to change the LQ model nor invoke phenomena over and above the classic 5 R’s of radiobiology/radiotherapy with the likely exception that for some tumors high doses of irradiation may produce enhanced antitumor immunity. Thus, we suggest that for most tumors the standard radiobiology concepts of the 5 R’s are sufficient to explain the clinical data, and the excellent results obtained from clinical studies are the result of the much larger biologically effective doses (BEDs) that are delivered with SRS and SBRT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Self-citationThe linear-quadratic formula and progress in fractionated radiotherapy
Fowler, J. F. (1989) · The British Journal of Radiology · doi:10.1259/0007-1285-62-740-679 · Cited by 2,252
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
ACTION OF X-RAYS ON MAMMALIAN CELLS
Puck, T. T., & Marcus, P. I. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.5.653 · Cited by 1,696 · cited 2×
“For many years after the publication of the first mammalian radiation survival curve by Puck and Marcus (3) using colony formation as the criterion for cell survival, investigators fitted survival curve data using the multitarget model, which describes cell survival (S) in terms of the dose (D), a parameter D0, repres…”
MethodDewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
Rothkamm, K., Krüger, I., Thompson, L. H., & Lübrich, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5706-5715.2003 · Cited by 1,189
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966 · cited 1×
“On the first of these questions, the preclinical data suggest that although radiation enhances the antigenicity of tumors (41-43), it has been reported by Dewan et al (44) that this is greater for fractionated irradiation than for single doses.”
BackgroundNordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Self-citationRadiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
Matsumura, S., Wang, B., Kawashima, N., Braunstein, S., Badura, M., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 711
Horiot, J. C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardani, G., Van Den Bogaert, W., Danczak, S., Bolla, M., et al. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90242-m · Cited by 676
Park, C., Papiez, L., Zhang, S., Story, M., & Timmerman, R. D. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.059 · Cited by 651
21 years of Biologically Effective Dose
Fowler, J. F. (2010) · The British Journal of Radiology · doi:10.1259/bjr/31372149 · Cited by 639
Douglas, B. G., & Fowler, J. F. (1976) · Radiation Research · doi:10.2307/3574407 · Cited by 604
Park, H. J., Griffin, R. J., Hui, S., Levitt, S. H., & Song, C. W. (2012) · Radiation Research · doi:10.1667/rr2773.1 · Cited by 549
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
Brizel, D. M., Dodge, R. K., Clough, R. W., & Dewhirst, M. W. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00102-4 · Cited by 548
Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation
Brown, J. M. (1979) · The British Journal of Radiology · doi:10.1259/0007-1285-52-620-650 · Cited by 526
Self-citationThe Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery
Kirkpatrick, J. P., Meyer, J. J., & Marks, L. B. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.04.005 · Cited by 516
Lethal and Potentially Lethal Lesions Induced by Radiation --- A Unified Repair Model
Curtis, S. B. (1986) · Radiation Research · doi:10.2307/3576798 · Cited by 480
Engaging the vascular component of the tumor response
Fuks, Z., & Kolesnick, R. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.014 · Cited by 446
Ahn, G.-O., & Brown, J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.032 · Cited by 432
Self-citationStereotactic body radiation therapy: a novel treatment modality
Lo, S. S., Fakiris, A. J., Chang, E. L., Mayr, N. A., Wang, J. Z., Papiez, L., Teh, B. S., McGarry, R. C., Cardenes, H. R., & Timmerman, R. D. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.188 · Cited by 419
Time-dose factors in radiotherapy: a review of the human data
Thames, H. D., Bentzen, S. M., Turesson, I., Overgaard, M., & Van den Bogaert, W. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90149-q · Cited by 405
Withers, H. R. (1975) · Advances in Radiation Biology · doi:10.1016/b978-0-12-035405-4.50012-8 · Cited by 303
Steel, G. G., McMillan, T. J., & Peacock, J. H. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914552491 · Cited by 290
Göthert, J. R., Gustin, S. E., van Eekelen, J. A. M., Schmidt, U., Hall, M. A., Jane, S. M., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2004) · Blood · doi:10.1182/blood-2003-11-3952 · Cited by 285
Lett, J. T., Ehmann, U. K., & Cox, A. (1975) · Cited by 283
Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays
Barendsen, G. W., & Broerse, J. J. (1970) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(70)90006-x · Cited by 255
K. SACHS, P. H. A. D. J. B. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143149 · Cited by 238
Astrahan, M. (2008) · Medical Physics · doi:10.1118/1.2969065 · Cited by 222
Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays
Barendsen, G. W., & Broerse, J. J. (1969) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(69)90051-6 · Cited by 183
The Repair-Misrepair Model in Radiobiology: Comparison to Other Models
Tobias, C. A. (1985) · Radiation Research · doi:10.2307/3576635 · Cited by 169
Carlson, D. J., Keall, P. J., Loo, B. W., Chen, Z. J., & Brown, J. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.007 · Cited by 166
Self-citationCarlson, D. J., Stewart, R. D., Semenenko, V. A., & Sandison, G. A. (2008) · Radiation Research · doi:10.1667/rr1046.1 · Cited by 164
Self-citationDuda, D. G., Cohen, K. S., Kozin, S. V., Perentes, J. Y., Fukumura, D., Scadden, D. T., & Jain, R. K. (2005) · Blood · doi:10.1182/blood-2005-08-3210 · Cited by 143
Abscopal Effect in a Patient with Melanoma
Hiniker, S. M., Chen, D. S., & Knox, S. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1203984 · Cited by 143
Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell Radiosensitizer
Brown, J. M., Diehn, M., & Loo, B. W. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.070 · Cited by 133
Self-citationBaumann, M. A., DuBois, W., & Suit, H. D. (1990) · Radiation Research · doi:10.2307/3577740 · Cited by 114
Brown, J. M., Brenner, D. J., & Carlson, D. J. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.003 · Cited by 113
Self-citationKallman, R. F., & Dorie, M. J. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90080-5 · Cited by 97
Kozin, S. V., Duda, D. G., Munn, L. L., & Jain, R. K. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs239 · Cited by 73
The Repair-Misrepair Model in Radiobiology: Comparison to Other Models
Tobias, C. A. (1985) · Radiation Research Supplement · doi:10.2307/3583515 · Cited by 61
Tumour cure rate and cell survival of a transplantable rat Rhabdomyosarcoma following X-irradiation
Reinhold, H. S., & Bree, C. D. (1968) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(68)90026-1 · Cited by 60
Stereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomes
Iyengar, P., & Timmerman, R. D. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0157 · Cited by 48
Cell-survival probability at large doses: an alternative to the linear-quadratic model
Hanin, L. G., & Zaider, M. (2010) · Physics in Medicine and Biology · doi:10.1088/0031-9155/55/16/005 · Cited by 45
Cited by
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
Recent Developments in Radiotherapy
Citrin, D. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1608986 · Cited by 488
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aaf26a · Cited by 440
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Sia, J., Szmyd, R., Hau, E., & Gee, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00041 · Cited by 378
Paganetti, H., Blakely, E., Carabe‐Fernandez, A., Carlson, D. J., Das, I. J., Dong, L., Grosshans, D., Held, K. D., Mohan, R., Moiseenko, V., et al. (2019) · Medical Physics · doi:10.1002/mp.13390 · Cited by 310
Self-citation
Metadata
- Authors
- Brown, J. M., Carlson, D. J., & Brenner, D. J.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 88
- Issue
- 2
- Pages
- 254-262
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2061137918
- Cited by
- 551
- References
- 49
- FWCI
- 54.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.